-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Zevra Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2013 to 2023.
- Zevra Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $3.94M, a 9.29% increase year-over-year.
- Zevra Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $8.17M, a 56.7% decline year-over-year.
- Zevra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $3.56M, a 77.4% decline from 2022.
- Zevra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $15.8M.
- Zevra Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$16.3M, a 126% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)